Prospective randomized study of the benefits of preoperative corticosteroid administration on hepatic ischemia-reperfusion injury and cytokine response in patients undergoing hepatic resection

HPB

Volumn 9, Issue 3, 2007, Pages 183-189

  Pulitanò, Carlo ^a   Aldrighetti, Luca ^a   Arru, Marcella ^a   Finazzi, Renato ^a   Soldini, Laura ^a   Catena, Marco ^a   Ferla, Gianfranco ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Corticosteroid administration; Hepatic ischemia reperfusion; Liver surgery; Surgical stress

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTITHROMBIN III; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CORTICOSTEROID; CYTOKINE; FRESH FROZEN PLASMA; INTERLEUKIN 6; METHYLPREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANALYSIS OF VARIANCE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE LEAKAGE; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; HEART DISEASE; HOSPITALIZATION; HUMAN; INCIDENCE; LENGTH OF STAY; LIVER FAILURE; LIVER ISCHEMIA; LIVER RESECTION; MALE; PLEURA EFFUSION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY;

EID: 34250628833     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1080/13651820701216984     Document Type: Article

References (43)

1. Wobbes, T., Bemelmans, BL, Kuypers, JH, Beerthuizen, GI and Theeuwes, AG (1990) Risk of postoperative septic complications after abdominal surgery treatment in relation to perioperative blood transfusion. Surg Gynecol Obstet, 171, p. 1990.
2. Makuuchi, M., Mori, T., Gunven, P., Yamazaki, S. and Hasegawa, H. (1987) Safety of hemihepatic vascular occlusion during resection of the liver. Surg Gynecol Obstet, 164, pp. 155-158.
3. Nagorney, DM, van Heerden, JA, Ilstrup, DM and Adson, MA (1989) Primary hepatic malignancy: Surgical management and determinants of survival. Surgery, 10, pp. 740-748.
4. Tsao, JI, Loftus, JP, Nagorney, DM, Adson, MA and Ilstrup, DM (1994) Trends in morbidity and mortality of hepatic resection for malignancy: A matched comparative analysis. Ann Surg, 220, pp. 199-205.
5. Huguet, C., Gavelli, A. and Bona, S. (1994) Hepatic resection with ischemia of the liver exceeding one hour. J Am Coll Surg, 178, pp. 454-458.
6. Ezaki, T., Seo, Y., Tomoda, H., Furusawa, M., Kanematsu, T. and Sugimachi, K. (1992) Partial hepatic resection under intermittent hepatic inflow occlusion in patients with chronic liver disease. Br J Surg, 79, pp. 224-226.
7. Selzener, N., Rudiger, H., Graf, R. and Clavien, P. (2003) Protective strategies against ischemic injury of the liver. Gastroenterology, 125, pp. 917-936.
8. Torzilli, G., Makuuchi, M., Inoue, K., Takayama, T., Sakamoto, Y. and Sugawara, Y. (1999) No-mortality liver resection for hepatocellular carcinoma in cirrhotic and non-cirrhotic patients: Is there a way? A prospective analysis of our approach. Arch Surg, 134, pp. 984-992.
9. Torzilli, G., Makuuchi, M., Midorikawa, Y., Sano, K., Inoue, K. and Takayama, T. (2001) Liver resection without total vascular exclusion: hazardous or beneficial? An analysis of our experience. Ann Surg, 233, pp. 167-175.
10. Wang, M., Sakon, M., Umeshita, K., Okuyama, M., Shiozaki, K. and Nagano, H. (2001) Prednisolone suppresses ischemia-reperfusion injury of the rat liver by reducing cytokine production and calpain μ activation. J Hepatol, 34, pp. 278-283.
11. Glanemann, M., Strenziok, R., Kuntze, R., Munchow, S., Dikopoulos, N. and Lippek, F. (2004) Ischemic preconditioning and methylprednisolone both equally reduce hepatic ischemia/reperfusion injury. Surgery, 135, pp. 203-214.
12. Figueroa, I. and Santiago-Delpin, EA (1975) Steroid protection of the liver during experimental ischemia. Surg Gynecol Obstet, 140, pp. 368-370.
13. Chiappa, AC, Makuuchi, M., Zbar, AP, Biella, F., Vezzoni, A. and Torzilli, G. (2004) Protective effect of methylprednisolone and of intermittent hepatic pedicle clamping during liver vascular inflow occlusion in the rat. Hepatogastroenterology, 51, pp. 1439-1444.
14. Glanemann, M., Munchow, S., Schirmeier, A., Al-Abadi, H., Lippek, F. and Langrehr, JM (2004) Steroid administration before partial hepatectomy with temporary inflow occlusion does not influence cyclin D1 and Ki-67 related liver regeneration. Langenbecks Arch Surg, 389, pp. 380-386.
15. Muratore, A., Ribero, D., Ferrero, A., Bergero, R. and Capussotti, L. (2003) Prospective randomized study of steroids in the prevention of ischaemic injury during hepatic resection with pedicle clamping. Br J Surg, 90, pp. 17-22.
16. Yamashita, Y., Shimada, M., Hamatsu, T., Rikimaru, T., Tanaka, S. and Shirabe, K. (2001) Effects of preoperative steroid administration on surgical stress in hepatic resection. Arch Surg, 136, pp. 328-333.
17. Shimada, M., Saitoh, A., Kano, T., Takenaka, K. and Sugimachi, K. (1996) The effects of a perioperative steroid pulse on surgical stress in hepatic resection. Int Surg, 81, pp. 49-51.
18. Emori, TG, Culver, DH, Horan, TC, Jarvis, WR, White, JW and Olson, DR (1991) National Nosocomial Infections Surveillance System (NNIS): description of surveillance methods. Am J Infect Control, 19, pp. 13-15.
19. Liu, DL, Jeppson, B., Hakansson, CH and Odslius, R. (1996) Multiple-system organ damage resulting from prolonged hepatic inflow interruption. Arch Surg, 131, pp. 442-447.
20. Farmer, DG, Amersi, F., Kupiec-Weglinski, JW and Busuttil, RW (2000) Current status of ischemia reperfusion injury in the liver. Transplant Rev, 14, pp. 106-126.
21. Holte, K. and Kehler, H. (2002) Perioperative single dose glucocorticoid administration: Pathophysiologic effects and clinical implications. J Am Coll Surg, 195, pp. 694-712.
22. Sauerland, S., Nagelschmidt, M., Mallmann, P. and Neugebauer, EA (2000) Risks and benefits of preoperative high dose methylprednisolone in surgical patients: A systematic review. Drug Saf, 23, pp. 449-461.
23. Tsuji, K., Eguchi, Y. and Kodama, M. (1996) Postoperative hypercoagulable state followed by hyperfibrinolysis related to wound healing after hepatic resection. J Am Coll Surg, 183, pp. 230-238.
24. Sinischalchi, A., Begliomini, B., De Pietri, L., Braglia, V., Gazzi, M. and Masetti, M. (2004) Increased prothrombin time and platelet counts in living donor right hepatectomy: Implications for epidural anesthesia. Liver Transpl, 10, pp. 1144-1149.
25. Rosenberg, RD (1989) Biochemistry of heparin antithrombin interactions, and the physiologic role of this natural anticoagulant mechanism. Am J Med, 87, pp. 2S-9S.
26. Wilson, R., Mammen, E., Robson, M., Heggers, J., Soulier, G. and DePoli, P. (1986) Antithrombin, prekallikrein, and fibronectin levels in surgical patients. Arch Surg, 121, pp. 635-640.
27. Hashimoto, K., Yamagishi, M., Sasaki, T., Nakano, M. and Kurosawa, H. (1994) Heparin and antithrombin III levels during cardiopulmonary bypass: Correlation with subclinical plasma coagulation. Ann Thorac Surg, 58, pp. 804-805.
28. Roemisch, J., Gray, E., Hoffmann, JN and Wiedermann, CJ (2002) Antithrombin: A new look at the actions of a serine protease inhibitor. Blood Coagul Fibrinolysis, 13, pp. 657-670.
29. Harada, N., Okajima, K., Uchiba, M., Kushimoto, S. and Isobe, H. (2004) Antithrombin reduces ischemia/reperfusion-induced liver injury in rats by activation of cyclooxygenase-1. Thromb Haemost, 92, pp. 550-558.
30. Shimada, M., Matsumata, T., Kamakura, T., Hayashi, H., Urata, K. and Sugimachi, K. (1994) Modulation of coagulation and fibrinolysis in hepatic resection: A randomized prospective control study using antithrombin III concentrates. Thromb Res, 74, pp. 105-114.
31. Pulitanò, C., Aldrighetti, L., Finazzi, R., Arru, M., Catena, M. and Ferla, G. (2005) Inhibition of cytokine response by methylprednisolone attenuates antithrombin III reduction following hepatic resection. Thromb Haemost, 93, pp. 1199-1200.
32. Matsutani, T., Onda, M., Sasajima, K. and Miyashita, M. (1998) Glucocorticoid attenuates a decrease of antithrombin III following major surgery. J Surg Res, 79, pp. 158-163.
33. Stouthard, JM, Levi, M., Hack, CE, Veenhof, CH, Romijn, HA and Sauerwein, HP (1996) Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thromb Haemost, 76, pp. 738-742.
34. Damas, P., Ledoux, D., Nys, M., Vrindts, Y., De Groote, D. and Franchimont, P. (1992) Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg, 215, pp. 356-362.
35. Colletti, LM, Remick, DG, Burtch, GD, Kunkel, SL, Strieter, RM and Campbell, DA (1990) Role of tumor necrosis factor-a in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest, 85, pp. 1936-1943.
36. Fujita, J., Marino, MW, Wada, H., Jungbluth, AA, Mackrell, PJ and Rivadeneira, DE (2001) Effect of TNF gene depletion on liver regeneration after partial hepatectomy in mice. Surgery, 129, pp. 48-54.
37. Wallenius, V., Wallenius, K. and Jansson, JO (2000) Normal pharmacologically-induced, but decreased regenerative liver growth in interleukin-6-deficient "IL-6 knockout" mice. J Hepatol, 33, pp. 967-974.
38. Wustefeld, T., Rakemann, T., Kubicka, S., Manns, MP and Trautwein, C. (2000) Hyperstimulation with interleukin 6 inhibits cell cycle progression after hepatectomy in mice. Hepatology, 32, pp. 514-522.
39. Shirabe, K., Takenaka, K., Yamamoto, K., Kawahara, N., Itasaka, H. and Nishizaki, T. (1997) Impaired systemic immunity and frequent infection in patients with candida antigen after hepatectomy. Hepatogastroenterology, 44, pp. 199-204.
40. Shimada, H., Ochiai, T., Okazumi, S., Matsubara, H., Nabeya, Y. and Miyazawa, Y. (2000) Clinical benefits of steroid therapy on surgical stress in patients with esophageal cancer. Surgery, 128, pp. 791-798.
41. Stubbs, SS (1975) Corticosteroids and bioavailability. Transplant Proc, 7, pp. 11-19.
42. Serracino-Inglott, F., Habib, N. and Mathie, R. (2001) Hepatic ischemia-reperfusion injury Am J Surg, 181, pp. 160-166.
43. Webel, ML, Ritts Jr, RE, Taswell, HF, Danadio Jr, JV and Woods, JE (1974) Cellular immunity after intravenous administration of methylprednisolone. J Lab Clin Med, 83, pp. 383-392.